Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Walgreens won't dispense abortion pills in some Republican states

Published 03/03/2023, 10:57 AM
Updated 03/03/2023, 11:01 AM
© Reuters. FILE PHOTO: Boxes of mifepristone, the first pill given in a medical abortion, are prepared for patients at Women's Reproductive Clinic of New Mexico in Santa Teresa, U.S., January 13, 2023.  REUTERS/Evelyn Hockstein
CVS
-

(Reuters) -Walgreens Boots Alliance Inc on Thursday said it will not dispense abortion pills in the states of 20 Republican attorneys general who have told the pharmacy chain it risked breaking the law should it dispense them to the states by mail.

The decision comes after the U.S. Food and Drug Administration allowed retail pharmacies to dispense mifepristone pills, including by mail, provided they are certified under special safety rules for the drug.

A Walgreens spokesperson said the pharmacy's decision was in response to a letter from the attorneys general. They said Walgreens intended to become a certified pharmacy and would only dispense in jurisdictions where it was legal to do so.

CVS Health Corp (NYSE:CVS), which also received the letter, did not immediately respond to Reuters' request for comment.

News website Politico first reported Walgreens' position on Thursday.

© Reuters. FILE PHOTO: Boxes of mifepristone, the first pill given in a medical abortion, are prepared for patients at Women's Reproductive Clinic of New Mexico in Santa Teresa, U.S., January 13, 2023.  REUTERS/Evelyn Hockstein

Medication abortion, which accounts for more than half of U.S. abortions, has drawn increasing attention since the Supreme Court in June overturned a landmark 1973 Roe v. Wade ruling that had recognized abortion as a constitutional right nationwide.

Mifepristone, used in combination with another drug, misoprostol, is approved for abortion within the first 10 weeks of pregnancy.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.